Dr. Jared Weiss, Vice President of GRACE and Associate Professor at UNC-Chapel Hill in Clinical Research, and the Thoracic Oncology Program at UNC Lineberger, discusses First Line EGFR-Based Therapy For Advanced Squamous Non-Small Cell Lung Cancer (NSCLC).

On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. Our third presentation discusses future directions in treatment, with Chad Pecot, MD.

On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. In this 2nd video of the series, Jared Weiss, MD joins us to discuss currently available treatment options.

On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. In this first video of the series, Dr. Chad Pecot, MD joins us to discuss 'What is squamous lung cancer?'

Dr. Jack West, Swedish Cancer Institute, discusses current trials seeking to determine the efficacy of combining immunotherapy agents in lung cancer.

Dr. Jack West, Swedish Cancer Institute, reviews the choices for a first-line chemotherapy regimen based on a squamous histology.

Dr. Jack West, Swedish Cancer Institute, addresses the issue of choosing a first-line chemotherapy regimen based on an adenocarcinoma histology.

Dr. Jared Weiss, UNC Lineberger Comprehensive Cancer Center, details the trends in lung cancer demographics and changes in histology by race and gender.

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

[powerpress]